New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: A role for the transcription factor sterol regulatory element binding protein-1c

Biochemical Journal

Volumn 366, Issue 2, 2002, Pages 377-391

  Foufelle, Fabienne ^a   Ferré, Pascal ^a  

^a INSERM   (France)

Author keywords

Carbohydrate response element binding protein; Forkhead; Glucokinase; Gluconeogenesis; SREBP

Indexed keywords

BIOSYNTHESIS; GLUCOSE; HORMONES; METABOLISM; PROTEINS;

NUTRIENTS;

GENES;

BINDING PROTEIN; CARBOHYDRATE; GLUCOSE; INSULIN; PANCREAS HORMONE; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR;

DNA SEQUENCE; ENERGY METABOLISM; GENE CONTROL; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCOGEN SYNTHESIS; GLYCOGENOLYSIS; HUMAN; LIPOGENESIS; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GLUCOSE; GLYCOLYSIS; HOMEOSTASIS; HUMANS; INSULIN; LIVER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTORS;

EID: 0036711553     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20020430     Document Type: Review

References (179)

1. Glucose transporters in the regulation of intestinal, renal and liver glucose fluxes
2. The mechanism by which rat liver glucokinase is inhibited by the regulatory protein
3. Short-term control of glucokinase activity: Role of a regulatory protein
4. The regulatory protein of glucokinase binds to the hepatocyte matrix, but, unlike glucokinase, does not translocate during substrate stimulation
5. Specific features of glycogen metabolism in the liver
6. Regulation of gluconeogenesis in liver
7. Short-term hormonal control of hepatic lipogenesis
8. The regulation of acetyl-CoA carboxylase - A potential target for the action of hypolipidemic agents
9. Molecular cloning of glucokinase cDNA. Developmental and dietary regulation of glucokinase mRNA in rat liver
10. Isolation and characterization of the transcriptionally regulated mouse liver (B-type) phosphofructokinase gene and its promoter
11. Induction of rat liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase mRNA by refeeding and insulin
12. Dietary control of aldolase B and L-type pyruvate kinase mRNAs in rat. Study of translational activity and hybridization with cloned cDNA probes
13. Transcriptional and post-transcriptional regulation of L-type pyruvate kinase gene expression in rat liver
14. Rat ATP citrate-lyase. Molecular cloning and sequence analysis of a full-length cDNA and mRNA abundance as a function of diet, organ, and age
15. Physiological regulation of acetyl-CoA carboxylase gene expression: Effects of diet, diabetes, and lactation on acetyl-CoA carboxylase mRNA
16. Effects of nutrients and hormones on transcriptional and post-transcriptional regulation of fatty acid synthase in rat liver
17. Hormonal regulation of mouse fatty acid synthase transcription in liver
18. Dietary regulation of stearoyl-CoA desaturase 1 gene expression in mouse liver
19. Molecular cloning of DNA sequences complementary to rat liver glucose-6-phosphate dehydrogenase mRNA. Nutritional regulation of mRNA levels
20. Effects of nutrients and insulin on transcriptional and post-transcriptional regulation of glucose-6-phosphate dehydrogenase synthesis in rat liver
21. Use of a cloned cDNA sequence to measure changes in 6-phosphogluconate dehydrogenase mRNA levels caused by thyroid hormone and dietary carbohydrate
22. Rapid synergistic interaction between thyroid hormone and carbohydrate on mRNAS14 induction
23. Interaction of dietary carbohydrate and glucagon in regulation of rat hepatic messenger ribonucleic acid S14 expression: Role of circadian factors and 3′,5′-cyclic adenosine monophosphate
24. Nutritional control of rat liver fatty acid synthase and S14 mRNA abundance
25. Direct evidence for a role of the spot 14 protein in the regulation of lipid synthesis
26. Spot 14 gene deletion increases hepatic de novo lipogenesis
27. Inhibition of transcription of PEPCK gene by insulin
28. Transcriptional regulation of glucokinase gene by insulin in cultured liver cells and its repression by the glucagon-cAMP system
29. Regulation of the expression of the L-type pyruvate kinase gene in adult rat hepatocytes in primary culture
30. Induction of fatty acid synthase gene expression by glucose in primary culture of rat hepatocytes
31. Glucose regulation of the acetyl-CoA carboxylase promoter Pl in rat hepatocytes
32. Glucose and insulin function through two distinct transcription factors to stimulate expression of lipogenic enzyme genes in liver
33. Insulin and dietary fructose induce stearoyl-CoA desaturase 1 gene expression of diabetic mice
34. Multihormonal regulation of PEPCK gene transcription. The dominant role of insulin
35. The repression of hormone-activated PEPCK gene expression by glucose is insulin-independent but requires glucose metabolism
36. The inhibitory effect of glucose on phosphoenolpyruvate carboxykinase gene expression in cultured hepatocytes is transcriptional and requires glucose metabolism
37. Regulation of gene expression by insulin
38. Insulin-regulated gene expression
39. Identification of a sequence in the PEPCK gene that mediates a negative effect of insulin on transcription
40. Identification of an insulin-responsive element in the promoter of the human gene for insulin-like growth factor binding protein-1
41. Functional analysis of glucocorticoid and insulin response sequences in the rat insulin-like growth factor-binding protein-1 promoter
42. The cyclic adenosine 3′,5′-monophosphate- and the glucocorticoid-dependent enhancers are targets for insulin repression of tyrosine aminotransferase gene transcription
43. A multicomponent insulin response sequence mediates a strong repression of mouse glucose-6-phosphatase gene transcription by insulin
44. Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: Correlation with changes in plasma triglyceride levels
45. Phosphatidylinositol 3-kinase, but not p70/p85 ribosomal S6 protein kinase, is required for the regulation of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by insulin. Dissociation of signaling pathways for insulin and phorbol ester regulation of PEPCK gene expression
46. Assessment of the roles of mitogen-activated protein kinase, phosphatidylinositol 3-kinase, protein kinase B, and protein kinase C in insulin inhibition of cAMP-induced phosphoenolpyruvate carboxykinase gene transcription
47. Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity
48. Activation of protein kinase B/Akt is sufficient to repress the glucocorticoid and cAMP induction of phosphoenolpyruvate carboxykinase gene
49. Protein kinase B/Akt mediates effects of insulin on hepatic insulin-like growth factor-binding protein-1 gene expression through a conserved insulin response sequence
50. Central role for phosphatidylinositide 3-kinase in the repression of glucose-6-phosphatase gene transcription by insulin
51. Dominant negative forms of Akt (protein kinase B) and atypical protein kinase Clambda do not prevent insulin inhibition of phosphoenolpyruvate carboxykinase gene transcription
52. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression
53. The Forkhead transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans
54. FKHR binds the insulin response element in the insulin-like growth factor binding protein-1 promoter
55. Negative regulation of the forkhead transcription factor FKHR by Akt
56. Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins
57. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence
58. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B
59. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1
60. Insulin slimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a wortmannin-sensitive pathway
61. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression
62. Gene- and activation-specific mechanisms for insulin inhibition of basal and glucocorticoid-induced insulin-like growth factor binding protein-1 and phosphoenolpyruvate carboxykinase transcription. Roles of forkhead and insulin response sequences
63. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis
64. ADD1: A novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation
65. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13
66. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells
67. SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein
68. CBP is required for sterol-regulated and sterol regulatory element-binding protein-regulated transcription
69. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells
70. Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes
71. Sterol regulatory element binding protein-1c expression and action in rat muscles: Insulin-like effects on the control of glycolytic and lipogenic enzymes and UCP3 gene expression
72. Dual DNA binding specificity of ADD1/SREBP1 controlled by a single amino acid in the basic helix-loop-helix domain
73. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
74. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood
75. Nuclear import of sterol regulatory element-binding protein-2, a basic helix-loop-helix-leucine zipper (bHLH-Zip)-containing transcription factor, occurs through the direct interaction of importin beta with HLH-Zip
76. Dimerization of sterol regulatory element-binding protein 2 via the helix-loop-helix-leucine zipper domain is a prerequisite for its nuclear localization mediated by importin beta
77. Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells
78. Autocatalytic processing of site-1 protease removes propeptide and permits cleavage of sterol regulatory element-binding proteins
79. Transport-dependent proteolysis of SREBP: Relocation of site-1 protease from Golgi to ER obviates the need for SREBP transport to Golgi
80. Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs
81. Sterol resistance in CHO cells traced to point mutation in SREBP cleavage activating protein
82. Topology of SREBP cleavage-activating protein, a polytopic membrane protein with a sterol-sensing domain
83. SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation
84. Independent regulation of sterol regulatory element binding proteins 1 and 2 in hamster liver
85. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice
86. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1
87. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose
88. Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes
89. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes
90. Sterol regulatory element-binding protein-1 is regulated by glucose at the transcriptional level
91. Induction of fatty acid synthase and S14 gene expression by glucose, xylitol and dihydroxyacetone in cultured rat hepatocytes is closely correlated with glucose 6-phosphate concentrations
92. Regulation of the rat SREBP-1c promoter in primary rat hepatocytes
93. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice
94. -/- mouse liver
95. Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes
96. Regulation of sterol regulatory-element binding protein 1 gene expression in liver: Role of insulin and protein kinase B/cAkt
97. Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene
98. Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene
99. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes
100. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis
101. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway
102. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta
103. Liver X receptors as insulin mediating factors in fatty acid and cholesterol biosynthesis
104. Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade
105. MAP kinases Erk1/2 phosphorylate sterol regulatory element-binding protein (SREBP)-1a at serine 117 in vitro
106. ADD1/SREBP-1c mediates insulin-induced gene expression linked to the MAP kinase pathway
107. Insulin stimulation of the fatty acid synthase promoter is mediated by the phosphatidylinositol 3-kinase pathway. Involvement of protein kinase B/Akt
108. Activation of protein kinase B/cAkt in hepatocytes is sufficient for the induction of expression of the gene encoding glucokinase
109. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes
110. Sterol regulatory element-binding protein-1c mimics the negative effect of insulin on phosphoenolpyruvate carboxykinase (GTP) gene transcription
111. CREB binding protein coordinates the function of multiple transcription factors including nuclear factor I to regulate phosphoenolpyruvate carboxykinase (GTP) gene transcription
112. Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice
113. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c
114. Diversity in cyclic nucleotide phosphodiesterase isoenzyme families
115. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene
116. Sterol regulation of fatty acid synthase promoter
117. Sterol regulation of acetyl coenzyme A carboxylase promoter requires two interdependent binding sites for sterol regulatory element binding proteins
118. The roles of sterol regulatory element-binding proteins in the transactivation of the rat ATP citrate-lyase promoter
119. Transcriptional regulation of the ATP citrate-lyase gene by sterol regulatory element-binding proteins
120. Identification of glycerol-3-phosphate acyltransferase as an adipocyte determination and differentiation factor 1- and sterol regulatory element-binding protein-responsive gene
121. Transcriptional activation of the stearoyl-CoA desaturase 2 gene by sterol regulatory element-binding protein/adipocyte determination and differentiation factor 1
122. Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2
123. Two tandem binding sites for sterol regulatory element binding proteins are required for sterol regulation of fatty-acid synthase promoter
124. Identification of an insulin response element in the fatty acid synthase promoter
125. Different sterol regulatory element-binding protein-1 isoforms utilize distinct co-regulatory factors to activate the promoter for fatty acid synthase
126. Sterol response element-binding protein 1c (SREBP1c) is involved in the polyunsaturated fatty acid suppression of hepatic S14 gene transcription
127. Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver
128. Differential metabolic effects of adenovirus-mediated glucokinase and hexokinase I overexpression in rat primary hepatocytes
129. Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism
130. Liver glycogen synthase deficiency: A rarely diagnosed entity
131. Signalling aspects of insulin resistance in skeletal muscle: Mechanisms induced by lipid oversupply
132. Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets
133. Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes
134. Regulation of the expression of lipogenic enzyme genes by carbohydrate
135. Glucose regulation of gene transcription
136. Glucose stimulation of lipogenic enzyme gene expression in cultured white adipose tissue
137. Glucose induces expression of stearoyl-CoA desaturase in 3T3-L1 adipocytes
138. Cell-specific carbohydrate metabolism regulates S14 gene transcription
139. Glucose regulates acetyl-CoA carboxylase gene expression in a pancreatic beta-cell line (INS-1)
140. The pyruvate kinase gene as a model for studies of glucose-dependent regulation of gene expression in the endocrine pancreatic beta-cell type
141. Respective roles of glucose, fructose, and insulin in the regulation of the liver-specific pyruvate kinase gene promoter
142. Differential effects of glucose and fructose on liver L-type pyruvate kinase gene expression in vivo
143. Liver hyperplasia and paradoxical regulation of glycogen metabolism and glucose-sensitive gene expression in GLUT2-null hepatocytes. Further evidence for the existence of a membrane-based glucose release pathway
144. Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats
145. Transcriptional glucose signaling through the glucose response element is mediated by the pentose phosphate pathway
146. Purification and characterization of a novel xylulose 5-phosphate-activated protein phosphatase catalysing dephosphorylation of fructose-6-phosphate 2-kinase:fructose-2,6-biphosphatase
147. Carbon flux via the pentose phosphate pathway regulates the hepatic expression of the glucose-6-phosphatase and phosphoenolpyruvate carboxykinase genes in conscious rats
148. Two glucose-signaling pathways in S14 gene transcription in primary hepatocytes: A common role of protein phosphorylation
149. AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes
150. The AMP-activated/SNF1 protein kinase subfamily: Metabolic sensors of the eukaryotic cell?
151. Yeast SNF1 is functionally related to mammalian AMP-activated protein kinase and regulates acetyl CoA carboxylase in vivo
152. Yeast carbon catabolite repression
153. The AMP-activated protein kinase - Fuel gauge of the mammalian cell?
154. The 5′-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex
155. Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase
156. Role of AMP-activated protein kinase in mechanism of metformin action
157. Role of AMP-activated protein kinase in the regulation by glucose of islet beta cell gene expression
158. Localization of the carbohydrate response element of the rat L-type pyruvate kinase gene
159. Cis-regulation of the L-type pyruvate kinase gene promoter by glucose, insulin and cyclic AMP
160. Elements responsible for hormonal control and tissue specificity of L-type pyruvate kinase gene expression in transgenic mice
161. Functional characterization of the L-type pyruvate kinase gene glucose response complex
162. Definition of the carbohydrate response element of the rat S14 gene
163. Involvement of a unique carbohydrate-responsive factor in the glucose regulation of rat liver fatty-acid synthase gene transcription
164. Glucose regulation of mouse S(14) gene expression in hepatocytes. Involvement of a novel transcription factor complex
165. Definition of the carbohydrate response element of the rat S14 gene. Context of the CACGTG motif the specificity of the carbohydrate regulation
166. Two CACGTG motifs with proper spacing dictate the carbohydrate regulation of hepatic gene transcription
167. Immunochemical characterization and transacting properties of upstream stimulatory factor isoforms
168. Carbohydrate regulation of hepatic gene expression: Evidence against a role for the upstream stimulatory factor
169. An indirect role for upstream stimulatory factor in glucose-mediated induction of pyruvate kinase and S14 gene expression
170. -/- mice
171. Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose
172. Chicken ovalbumin upstream promoter-transcription factor II, a new partner of the glucose response element of the L-type pyruvate kinase gene, acts as an inhibitor of the glucose response
173. A novel factor binding to the glucose response elements of liver pyruvate kinase and fatty acid synthase genes
174. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver
175. Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein
176. WBSCR14, a gene mapping to the Williams-Beuren syndrome deleted region, is a new member of the Mix transcription factor network
177. MondoA, a novel basic helix-loop-helix-leucine zipper transcriptional activator that constitutes a positive branch of a max-like network
178. Glucose and cAMP: Adversaries in the regulation of hepatic gene expression
179. Carbohydrate regulation of the rat L-type pyruvate kinase gene requires two nuclear factors: LF-A1 and a member of the c-myc family